Will be a TO I reckon. Why would the pharma want to share the product with their peers? With their deep pocket, buying out noxopharm will be loose change.
Ann: Noxopharm IONIC Immuno-Oncology Trial Commences, page-6
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 11.0¢ | $45.44K | 375.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 629029 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 84087 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |